ArticleACS omega2026
Binding of Steroid Hormones to the FA1 and FA6 Sites of Human Serum Albumin through Computational Biology and Quantum Biochemistry.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human serum albumin (HSA) plays a significant role in the transportation of steroid hormones through noncovalent interactions of low affinity. The binding between HSA and estradiol and testosterone has been a subject of investigation through experimental tools. While some studies suggest that HSA carries sex steroid hormones through a unique binding site, others propose that this interaction occurs through two or three binding sites, indicating a lack of consensus regarding the mechanisms underlying these interactions. In view of this, the present study used molecular docking, molecular dynamics, and quantum biochemistry to obtain more insights into the binding of estradiol, dihydrotestosterone, and testosterone to HSA. Molecular docking indicated that fatty acid binding sites 1 (FA1) and 6 (FA6), located respectively in subdomain IB and between subdomains IIA and IIB, are particularly promising targets for more robust investigations. The hormones exhibited considerable flexibility within subdomain IB, with dihydrotestosterone showing the greatest structural stability. This hormone also demonstrated the highest stability within FA6, which was markedly greater than that observed at FA1. Quantum mechanics calculations suggested that the three hormones exhibit similar interaction energies for the FA1 binding site, with estradiol predicting a marginally lower energy of interaction. Dihydrotestosterone was the only hormone that exhibited both the highest structural stability and the lowest energy of interaction when bound to FA6. Overall, the results suggest that the FA1 and FA6 binding sites generally do not favor the formation of strong interactions, except in the HSA-FA6:Dihydrotestosterone complex, where the hydrogen bond LEU481-(HN-main chain):DHT-(O17) played a crucial role in stabilizing conformations of both high and low theoretical energy of interaction. This observation aligns with the established fact that the interaction between HSA and sex steroid hormones is weak. Moreover, the present study found that dihydrotestosterone exhibits a heightened tendency to bind to FA6 in comparison to estradiol and testosterone. This tendency may critically regulate DHT serum transport, bioavailability, and half-life, while also creating a pharmacologically relevant hotspot for competition with fatty acids and FA6-targeting drugs, with potential implications for hormonal homeostasis and drug-hormone interactions in physiological and pathological conditions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.